Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Laurent Chanroux
  • March 5, 2015
  • Articles

The impact on patient outcomes in the treatment of non-radiographic axial spondyloarthritis

The impact on patient outcomes in the treatment of non-radiographic axial spondyloarthritis

The Therapy Watch nr-axial SpA monthly study was launched in July 2014 among a panel of 200 EU5 rheumatologists to provide insight into the characteristics of nr-axSpA patients, existing treatment strategies and potential barriers to prescribing.

The Therapy Watch nr-axial SpA monthly study was launched in July 2014 among a panel of 200 EU5 rheumatologists to provide insight into the characteristics of nr-axSpA patients, existing treatment strategies and potential barriers to prescribing.Axial spondyloarthritis (axSpA) is still a relatively new term in rheumatology and the recent nomenclature separating axial vs. peripheral, and radiographic and non-radiographic spondyloarthritis has changed the perspective of ankylosing spondylitis (AS) by switching the focus towards earlier diagnosis and treatment of the disease.

read more »